Login / Signup

Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection.

Ploenchan ChetchotisakdSiriluck AnunnatsiriRatanavadee NanagaraArnone NithichanonGanjana Lertmemongkolchai
Published in: Journal of immunology research (2018)
IVCY therapy might be an alternative treatment for AOID patients infected with M. abscessus and refractory to antimycobacterial therapy.
Keyphrases
  • end stage renal disease
  • high dose
  • ejection fraction
  • mycobacterium tuberculosis
  • prognostic factors
  • low dose
  • immune response
  • dendritic cells